DXCM Q3 2022 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$770M+18.4% YoY

Gross Profit

$494M64.2% margin

Operating Income

$148M19.2% margin

Net Income

$101M13.1% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+10.5%

Cash Flow

Operating Cash Flow

$293M

Free Cash Flow

$185M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$4.9B

Total Liabilities

$3.1B

Stockholders' Equity

$1.8B

Cash & Equivalents

$698M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$770M	$650M	+18.4%
Gross Profit	$494M	$447M	+10.6%
Operating Income	$148M	$118M	+24.7%
Net Income	$101M	$71M	+42.7%

Geographic Segments

UNITED STATES

$573M75%

Non-US

$196M25%